Drug screening and molecular profiling identifies INKA1 as a predictive biomarker for sensitivity to MAPK inhibition-antimitotic combination treatment in pancreatic ductal adenocarcinoma

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

  • Prson Gautam
  • Markus Vaha-Koskela
  • Max Tomlinson
  • Adrienne D. Cox
  • Channing J. Der
  • Tero Aittokallio
  • Wennerberg, Krister
Original languageEnglish
Article numberA137
JournalMolecular Cancer Therapeutics
Volume18
Issue number12
ISSN1535-7163
DOIs
Publication statusPublished - 2019

ID: 237802836